MetaCap

InnovAge (INNV) vs Strata Critical Medical (SRTA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

InnovAge (INNV) has outperformed Strata Critical Medical (SRTA) over the past year, gaining 74.5% versus a gain of 8.6%. Over five years, INNV leads with a +20.4% price change compared with -46.8% for SRTA. InnovAge is the larger company by market cap ($1.25 billion vs $407.3 million), about 3.1 times the size, while Strata Critical Medical is growing revenue faster (+34.3% vs +15.9%).

Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus -0.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INNV+74.48%SRTA+8.57%
+138%+61%-16%
Nov 21, 20251 yearNov 20, 2026
INNV+8.92%SRTA-52.80%
+49%-18%-84%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INNV versus SRTA key metrics
MetricINNVSRTA
Share price$9.16$4.56
Market cap$1.25B$407.30M
1-day change+2.81%-5.59%
YTD return+76.49%-5.20%
1-year return+74.48%+8.57%
5-year return+20.37%-46.79%
P/E ratio (TTM)152.67—
Forward P/E18.32—
EPS (TTM)$0.06$-0.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$989.71M$197.14M
Revenue growth (YoY)+15.93%+34.28%
Net income (latest FY)$-2.54M$41.35M
Gross margin23.01%20.86%
Operating margin0.26%-11.34%
Net margin-0.26%20.97%
52-week high$12.64$6.50
52-week low$4.70$3.95
Distance from 52-week high-27.53%-29.85%
Analyst consensusnonestrong_buy
Avg. price target upside+31.00%+111.18%
Average volume595.71K982.75K
Shares outstanding136.46M89.32M
Employees2,500327
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • InnovAge is about 3.1 times larger than Strata Critical Medical by market value ($1.25B vs $407.30M).
  • INNV has outperformed SRTA by 65.9 percentage points over the past year.
  • Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus -0.3 cents for InnovAge.
  • Strata Critical Medical grew revenue faster in its latest fiscal year (+34.28% vs +15.93%).

About InnovAge

INNV stock →

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors.

Health Care · Medical/Nursing Services · 2,500 employees

About Strata Critical Medical

SRTA stock →

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.

Health Care · Medical/Nursing Services · 327 employees

INNV vs SRTA FAQ

Which is bigger, InnovAge or Strata Critical Medical?

InnovAge (INNV) is larger, with a market capitalization of $1.25B compared with $407.30M for Strata Critical Medical (SRTA).

Which stock has performed better over the past year, INNV or SRTA?

INNV returned +74.48% over the past 12 months, compared with +8.57% for SRTA (price return, excluding dividends). Past performance does not predict future results.

Are InnovAge and Strata Critical Medical in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons